Pharmacotherapeutic Considerations for Using Colchicine to Treat Idiopathic Pericarditis in the USA Nicholas C. Schwier Leading Article 05 August 2015 Pages: 295 - 306
Time to Reconsider Dabigatran 110 mg in the USA Inmaculada Hernandez Current Opinion 12 June 2015 Pages: 307 - 309
Risks and Benefits of Low Molecular-Weight Heparin and Target-Specific Oral Anticoagulant Use for Thromboprophylaxis in Medically Ill Patients Genevieve HaleMichael Brenner Review Article 09 May 2015 Pages: 311 - 322
Non-Vitamin K Antagonist Oral Anticoagulants: New Choices for Patient Management in Atrial Fibrillation Walid Saliba Review Article Open access 09 June 2015 Pages: 323 - 335
One-Year Post-Discharge Resource Utilization and Treatment Patterns of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention and Treated with Ticagrelor or Prasugrel Jason C. SimeoneCliff MolifePatrick L. McCollam Original Research Article 10 September 2015 Pages: 337 - 350
Edoxaban: A Review in Nonvalvular Atrial Fibrillation Paul L. McCormack Adis Drug Evaluation 14 September 2015 Pages: 351 - 361
Perindopril/Amlodipine (Prestalia®): A Review in Hypertension Matt ShirleyPaul L. McCormack Adis Drug Evaluation 04 September 2015 Pages: 363 - 370
Comment on: “Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag” Nuggehally R. Srinivas Letter to the Editor 21 August 2015 Pages: 371 - 372
Authors’ Reply to Srinivas: “Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag” Priska KaufmannJasper Dingemanse Letter to the Editor 21 August 2015 Pages: 373 - 374